Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,278 | 207 | 99.0% |
| Education | $31.97 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $516.25 | 32 | $0 (2020) |
| Amgen Inc. | $494.03 | 36 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $249.08 | 16 | $0 (2019) |
| GlaxoSmithKline, LLC. | $187.70 | 13 | $0 (2020) |
| AbbVie Inc. | $186.39 | 14 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $178.83 | 13 | $0 (2020) |
| Lilly USA, LLC | $139.71 | 3 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $124.14 | 1 | $0 (2022) |
| Novo Nordisk Inc | $113.60 | 7 | $0 (2020) |
| Amarin Pharma Inc. | $107.62 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $148.32 | 4 | Lilly USA, LLC ($94.97) |
| 2023 | $66.77 | 4 | AbbVie Inc. ($30.25) |
| 2022 | $124.14 | 1 | OPKO Pharmaceuticals, LLC ($124.14) |
| 2020 | $182.78 | 14 | AstraZeneca Pharmaceuticals LP ($36.89) |
| 2019 | $637.58 | 51 | Amgen Inc. ($174.07) |
| 2018 | $922.69 | 65 | Amgen Inc. ($192.72) |
| 2017 | $1,228 | 72 | AstraZeneca Pharmaceuticals LP ($184.42) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $94.97 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: VACCINES | ||||||
| 02/04/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $124.14 | General |
| Category: NEPHROLOGY | ||||||
| 09/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Respiratory | ||||||
| 08/21/2020 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $13.46 | General |
| Category: Endocrinology | ||||||
| 05/08/2020 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Endocrinology | ||||||
| 03/02/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 02/18/2020 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), ADACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Vaccines | ||||||
| 02/17/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: IMMUNOLOGY | ||||||
| 02/12/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Diabetes | ||||||
| 01/27/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, STEGLUJAN | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/17/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Central Nervous System | ||||||
| 01/14/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: DIABETES | ||||||
| 01/08/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Cardiology | ||||||
| 12/18/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,528 | 3,740 | $391,572 | $238,491 |
| 2022 | 32 | 2,522 | 3,739 | $402,672 | $243,086 |
| 2021 | 30 | 2,553 | 3,901 | $394,734 | $246,936 |
| 2020 | 31 | 2,706 | 4,434 | $410,988 | $233,609 |
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 5 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 14 | 16 | $5,200 | $3,580 | 68.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 30 | 30 | $4,320 | $3,550 | 82.2% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 138 | 190 | $8,610 | $3,273 | 38.0% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 12 | 12 | $3,300 | $2,722 | 82.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 11 | 11 | $2,200 | $2,046 | 93.0% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2020 | 13 | 27 | $3,375 | $2,045 | 60.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 295 | 630 | $7,560 | $1,874 | 24.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 17 | 27 | $4,050 | $1,541 | 38.1% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2020 | 14 | 33 | $2,475 | $1,063 | 42.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2020 | 27 | 30 | $1,500 | $856.31 | 57.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 40 | 67 | $2,479 | $809.81 | 32.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 42 | 42 | $1,344 | $796.30 | 59.2% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 11 | 11 | $880.00 | $538.15 | 61.2% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 17 | 20 | $500.00 | $326.64 | 65.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 23 | 35 | $525.00 | $313.10 | 59.6% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 51 | 67 | $1,340 | $301.16 | 22.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2020 | 51 | 51 | $1,530 | $222.57 | 14.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 11 | 11 | $385.00 | $215.38 | 55.9% |
| 81003 | Automated urinalysis test | Office | 2020 | 36 | 57 | $1,140 | $127.50 | 11.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 37 | 60 | $600.00 | $86.68 | 14.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 12 | 16 | $480.00 | $67.21 | 14.0% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2020 | 11 | 11 | $550.00 | $63.28 | 11.5% |
About Dr. Thomas Stack, D.O
Dr. Thomas Stack, D.O is a Family Medicine healthcare provider based in Montville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891808572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Stack, D.O has received a total of $3,310 in payments from pharmaceutical and medical device companies, with $148.32 received in 2024. These payments were reported across 211 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,278).
As a Medicare-enrolled provider, Stack has provided services to 10,309 Medicare beneficiaries, totaling 15,814 services with total Medicare billing of $962,122. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Montville, NJ
- Active Since 08/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891808572
Products in Payments
- FARXIGA (Drug) $303.21
- Repatha (Biological) $243.03
- XARELTO (Drug) $222.95
- SYMBICORT (Drug) $170.01
- Aimovig (Biological) $126.69
- RAYALDEE (Drug) $124.14
- Prolia (Biological) $114.31
- Vascepa (Drug) $107.62
- JANUVIA (Drug) $104.37
- ZEPBOUND (Drug) $94.97
- Creon (Drug) $88.32
- ANORO (Drug) $81.91
- VYVANSE (Drug) $63.45
- KEVEYIS (Drug) $62.98
- Edarbi (Drug) $60.09
- Victoza (Drug) $55.55
- ENTRESTO (Drug) $53.35
- Trintellix (Drug) $49.40
- Zubsolv (Drug) $48.14
- UBRELVY (Drug) $44.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Montville
Dr. Arnold Pallay, Md, MD
Family Medicine — Payments: $10,226
Dr. Frank Iannetta, M.d, M.D
Family Medicine — Payments: $6,224
Alyssa Huncken, Md, MD
Family Medicine — Payments: $2,056
Dr. Pareen Lapsiwala, D.o, D.O
Family Medicine — Payments: $970.16
Zunera Yaqub, M.d, M.D
Family Medicine — Payments: $831.03
Dr. Sandra Hoenig, M.d,, M.D,
Family Medicine — Payments: $720.56